Why Returning Customers Choose EverydayMeds
Your Mounjaro 5mg Reorder - Now £174.99
As a valued returning customer, your Mounjaro 5mg prescription costs just £174.99 instead of the standard £199.99. This £25 saving applies to every single reorder, recognising your loyalty to EverydayMeds. Your prescription-only tirzepatide treatment continues at the most competitive price available, with the same clinical excellence you've come to expect.
Streamlined Reordering Process
Reordering your Mounjaro 5mg takes minutes, not hours. Our system recognises your previous clinical assessment, expediting your prescription review. Simply log into your account, select your dosage, and proceed to checkout where your £25 discount applies automatically. No codes needed - your loyalty savings are built in.
Bundle Options for Extended Treatment
Planning ahead? Our Progress Duo bundle (5mg + 7.5mg) costs £369.99 for returning customers, perfect if you're ready to progress your dosage. The Progress Trio (5mg, 7.5mg, 10mg) provides three months of treatment for £634.99, maximising your savings whilst ensuring treatment continuity.
Express Service Available
Need your Mounjaro 5mg urgently? Upgrade to our express service for 24-hour prescription approval and next-day delivery. This premium option ensures your treatment schedule stays on track, particularly important for your once-weekly tirzepatide injections.
Quality Assurance You Trust
Every Mounjaro 5mg pen comes from our GPhC-registered UK pharmacy, maintaining the same quality standards that brought you back. Your tirzepatide treatment activates GIP and GLP-1 hormones, supporting appetite regulation and promoting feelings of fullness alongside your reduced-calorie diet and increased physical activity.
Secure Reordering Today
Your account dashboard shows your treatment history, making reordering straightforward. Select Mounjaro 5mg, confirm your delivery address, and complete checkout to secure your £174.99 price. Your prescription undergoes the same thorough clinical review, ensuring continued treatment safety and effectiveness.
